医学と薬学　73/8　2016年8月号

出版社： 自然科学社
発行日： 2016-07-27
分野： 薬学  >  雑誌
ISSN： 03893898
雑誌名：
特集： アルコールと臓器障害
電子書籍版： 2016-07-27 （第1版第1刷）
書籍・雑誌
≪全国送料無料でお届け≫
品切れ

2,200 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

1,320 円(税込)

購入する

目次

  • 医学と薬学　73/8　2016年8月号

    ―目次―

    特集　アルコールと臓器障害

    巻頭言
    アルコール性臓器障害
    アルコールと循環器疾患
    アルコールと消化管
    アルコールと肝臓
    アルコールと膵炎
    アルコールと神経・精神障害
    アルコール健康障害対策基本法

    研究
    　タゾピペ(R) 配合静注用「日医工」のin vitro における
    　　各種病原細菌に対する抗菌作用

    前臨床試験
    　ラットの空間認知記憶に及ぼすコリン塩化物長期摂取の影響
    　アダパレンによる副作用症状に対する十味敗毒湯の改善効果

    症例報告
    　大量腹水･腎不全を併発した生体肝移植後
    　　サイトメガロウイルス感染に対し投与した
    　　ガンシクロビルの血中･腹水中濃度測定を行った小児の1例

    Diagnosis
    　新規開発品「ルミパルスプレストHTLV-I/II」の性能評価
    　新規試薬Elecsys Anti-HBs IIの基礎的検討と他試薬との相関

    Health Care
    　高吸収化クルクミン製剤の肝機能への作用
    　ブタ肝臓分解物のヒト認知機能改善効果

    Cosmetic
    　マッサージを併用した美顔器・化粧品による
    　　リフトアップ・肌改善効果　
    　アミノ酸を配合した保湿ジェルによる肌改善効果

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

【特集 アルコールと臓器障害】

P.950 掲載の参考文献
1) 横山顕 : アルコールと癌, アルコール医学・医療の最前線2015 Update. 医学のあゆみ 254 : 924-928, 2015.
 
2) Fujita N, Takei Y : Alcohol consumption and metabolic syndrome. Hepatol Res 41 : 287-295, 2011.
PubMed
3) アルコール医学生物学研究会編 : アルコール性肝障害診断基準2011年版, 響文社, 札幌, 2012.
 
4) 竹井謙之 : アルコール性肝障害の病態概念の変遷. 竹井謙之編, NASH・アルコール性肝障害の診療を極める, Hepatology Practice Vol. 2, pp. 214-220, 文光堂, 東京, 2013
 
5) 藤田尚己, 岩佐元雄, 竹井謙之他 : アルコール性肝障害における肝機能等身体に及ぼす飲酒量低減の効果. 日本アルコール・薬物医学会雑誌 48 : 32-38, 2013.
 
6) Becker U, Deis A, Sorensen TI et al : Prediction of risk of liver disease by alcohol intake, sex, and age : a prospective population study. Hepatology 23 : 1025-1029, 1996.
PubMed
7) 樋口進 : 離脱症状からの回復後長期間を経たアルコール依存症に対する治療薬アカンプロサートの有効性. Frontiers in Alcoholism 3 (1) : 56-58, 2015.
Medical*Online
8) 高瀬幸次郎, 猪野亜朗, 片岡千都子編 : アルコール救急多機関連携マニュアル, 四日市アルコールと健康を考えるネットワーク.
 
9) 内閣府HP : アルコール健康障害対策, http://www8.cao.go.jp/alcohol/
 
10) 竹井謙之企画 : 特集アルコール医学・医療の最前線2015 Update. 医学のあゆみ 254 (10), 2015.
 
P.960 掲載の参考文献
1) Fauchier L, Babuty D, Poret P et al : Comparison of long-term outcome of alcoholic and idiopathic dilated cardiomyopathy. Eur Heart J 21 : 306-314, 2000.
PubMed
2) Holmes MV, Dale CE, Zuccolo L et al : Association between alcohol and cardiovascular disease : Mendelian randomisation analysis based on individual participant data. BMJ 349 : g4164, 2014. 3) Fernandez-Sola J : Cardiovascular risks and benefits of moderate and heavy alcohol consumption. Nat Rev Cardiol 12 : 576-587, 2015.
 
4) Gallego-Delgado M, Garcia-Pavia P : Alcoholic cardiomyopathy. World J Cardiol 6 : 771-781, 2014.
PubMed
5) Lazarevic AM, Nakatani S, Neskovic AN et al : Early changes in left ventricular function in chronic asymptomatic alcoholics : relation to the duration of heavy drinking. J Am Coll Cardiol 35 : 1599-1606, 2000.
 
6) Urbano-Marquez A, Estruch R, Navarro-Lopez F et al : The effect of alcoholism on skeletal and cardiac muscle. N Engl J Med 320 : 409-415, 1989.
PubMed
7) Kupari M, Koskinen P, Suokas A et al : Left ventricular filling impairment in asymptomatic chronic alcoholics. Am J Cardiol 66 : 1473-1477, 1990.
PubMed
8) Molina PE, Gardner JD, Souza-Smith FM et al : Alcohol abuse : critical pathophysiological processes and contribution to disease burden. Physiology (Bethesda) 9 : 203-215, 2014.
 
9) Urbano-Marquez A, Estruch R, Fernandez-Sola J et al : The greater risk of alcoholic cardiomyopathy and myopathy in women compared to men. JAMA 274 : 149-154, 1995.
PubMed
10) Skotzko CE, Vrinceanu A, Krueger L et al : Alcohol use and congestive heart failure : incidence, importance, and approaches to improved history taking. Heart Fail Rev 14 : 51-55, 2009.
PubMed
11) Kloner RA, Rezkalla SH : To drink or not to drink? That is the question. Circulation 116 : 1306-1317, 2007.
PubMed
12) Goncalves A, Claggett B, Jhund PS et al : Alcohol consumption and risk of heart failure : the Atherosclerosis Risk in Communities Study. Eur Heart J 36 : 939-945, 2015.
PubMed
13) Bryson CL, Mukamal KJ, Mittleman MA et al : The association of alcohol consumption and incident heart failure : the Cardiovascular Health Study. J Am Coll Cardiol 48 : 305-311, 2006.
PubMed
14) Krenz M, Korthuis RJ : Moderate ethanol ingestion and cardiovascular protection : from epidemiologic associations to cellular mechanisms. J Mol Cell Cardiol 52 : 93-104, 2012.
PubMed
15) Fernandez-Sola J, Fatjo F, Sacanella E et al : Evidence of apoptosis in alcoholic cardiomyopathy. Hum Pathol 37 : 1100-1110, 2006.
PubMed
16) Segel LD, Rendig SV, Choquet Y et al : Effects of chronic graded ethanol consumption on the metabolism, ultrastructure, and mechanical function of the rat heart. Cardiovasc Res 9 : 649-663, 1975.
 
17) Meehan J, Piano MR, Solaro RJ et al : Heavy longterm ethanol consumption induces an α-to β-myosin heavy chain isoforms transition in rat. Basic Res Cardiol 94 : 481-488, 1999.
 
18) Piano MR, Rosenblum C, Solaro RJ, et al : Effect of pimobendan and isoproterenol in the alcoholic myocardium. J Cardiovasc Pharmacol 33 : 237-242, 1999.
 
19) Guppy LJ Littleton JM : Binding characteristics of the calcium channel antagonist [3H] -nitrendipine in tissues from ethanol dependent rat. Alcohol Alcoholism 29 : 283-293, 1994.
PubMed
20) Cheng CP, Cheng HJ, Cunningham C : Angiotensin II type 1 receptor blockade prevents alcoholic cardiomyopathy. Circulation 114 : 226-236, 2006.
PubMed
21) 竹端均, 和泉徹 : アルコール性心疾患. 日本臨牀 58 : 151-156, 2000.
Medical*Online
22) Tonelo D, Providencia R, Goncalves L : Holiday heart syndrome revisited after 34 years. Arq Bras Cardiol 101 : 183-189, 2013.
PubMed
23) George A, Figueredo VM : Alcohol and arrhythmias : a comprehensive review. J Cardiovasc Med (Hagerstown) 11 : 221-228, 2010.
PubMed
24) Gavazzi A, De Maria R, Parolini M, et al : Alcohol abuse and cardiomyopathy in men. Am J Cardiol 85 : 1114-1118, 2000.
PubMed
25) Lehrke S, Lossnitzer D, Schob M et al : Use of cardiovascular magnetic resonance for risk stratification in chronic heart failure : prognostic value of late gadolinium enhancement in patients with non-ischaemic dilated cardiomyopathy. Heart 97 : 727-732, 2011.
PubMed
26) Perazzolo Marra M, De Lazzari M, Zorzi A et al : Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy. Heart Rhythm 11 : 856-863, 2014.
PubMed
27) 坂本央, 長谷部直幸 : アルコール性心筋障害. 最新医学別冊, アルコール性肝障害 : 175-182, 2009.
 
28) Ugander M, Oki AJ, Hsu LY et al : Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. Eur Heart J 33 : 1268-1278, 2012.
PubMed
29) Liu CY, Liu YC, Wu C et al : Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping : MESA (Multi-Ethnic Study of Athero sclerosis). J Am Coll Cardiol 62 : 1280-1287, 2013.
 
30) Iles L, Pfluger H, Phrommintikul A et al : Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol 52 : 1574-1580, 2008.
PubMed
31) Yusuf S, Hawken S, Ounpuu S et al : Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study) : case control study. Lancet 364 : 937-952, 2004.
PubMed
32) Hvidtfeldt UA, Tolstrup JS, Jakobsen MU et al : Alcohol intake and risk of coronary heart disease in younger, middle-aged, and older adults. Circulation 121 : 1589-1597, 2010.
PubMed
33) Brien SE, Ronskley PE, Turner BJ et al : Effect of alcohol consumption on biological markers associated with risk of coronary heart disease : systematic review and meta-analysis of interventional studies. BMJ 342 : d636, 2011.
 
34) Brinton EA : Effects of ethanol intake on lipoproteins and atherosclerosis. Curr. Opin. Lipidol 21 : 346-351, 2010.
PubMed
35) Facchini F, Chen YD, Reaven GM : Light-to-moderate alcohol intake is associated with enhanced insulin sensitivity. Diabetes Care 17 : 115-119, 1994.
PubMed
36) Vazquez-Agell M, Sacanella E, Tobias E et al : Inflammatory markers of atherosclerosis are decreased after moderate consumption of cava (sparkling wine) in men with low cardiovascular risk. J Nutr 137 : 2279-2284, 2007.
PubMed
37) Miceli M, Alberti L, Bennardini F et al : Effect of low doses of ethanol on platelet function in longlife abstainers and moderate-wine drinkers. Life Sci 73 : 1557-1566, 2003.
PubMed
38) Petrone AB, Gaziano JM, Djousse L : Alcohol consumption and risk of death in male physicians with heart failure. Am J Cardiol 114 : 1065-1068, 2014.
PubMed
39) Knott CS, Coombs N, Stamatakis E et al : All cause mortality and the case for age specific alcohol consumption guidelines : pooled analyses of up to 10 population based cohorts. BMJ 350 : h384, 2015.
PubMed
40) Chiva-Blanch G, Arranz S, Lamuela-Raventos RM et al : Effects of wine, alcohol and polyphenols on cardiovascular disease risk factors : evidences from human studies. Alcohol Alcohol 48 : 270-277, 2013.
PubMed
41) Patra J, Taylor B, Irving H et al : Alcohol consumption and the risk of morbidity and mortality for different stroke types-a systematic review and meta-analysis. BMC Public Health 10 : 258, 2010.
PubMed
42) Mukamal KJ, Ascherio A, Mittleman MA et al : Alcohol and the risk for ischemic stroke in men : the role of drinking patters and usual beverage. Ann Intern Med 142 : 11-19, 2005.
 
43) Crestani CC, Lopes da Silva A, Scopinho AA et al : Cardiovascular alterations at different stages of hypertension development during ethanol consumption : time-course of vascular and autonomic changes. Toxicol Appl Pharmacol 280 : 245-255, 2014.
PubMed
P.966 掲載の参考文献
1) IARC : IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol. 96. IARC, Lyon, 2010.
 
2) 渡辺寛 : 食道・頭頸部重複癌の現状と対策. 日本気管食道科学会会報 49 : 151-155, 1998.
 
3) Jarl J, Gerdtham UG : Time pattern of reduction in risk of oesophageal cancer following alcohol cessation-a meta-analysis. Addiction 107 : 1234-1243, 2012.
PubMed
4) Ozasa K : Japan Collaborative Cohort Study for Evaluation of Cancer. Alcohol use and mortality in the Japan Collaborative Cohort Study for Evaluation of Cancer (JACC). Asian Pac J Cancer Prev 8 Suppl : 81-88, 2007.
 
5) Yokoyama A, Omori T, Yokoyama T : Alcohol and aldehyde dehydrogenase polymorphisms and a new strategy for prevention and screening for cancer in the upper aerodigestive tract in East Asians. Keio J Med 59 : 115-130, 2010.
 
6) Yokoyama A, Yokoyama T, Omori T : Past and current tendency for facial flushing after a small dose of alcohol is a marker for increased risk of upper aerodigestive tract cancer. Cancer Sci 101 : 2497-2498, 2010.
PubMed
7) Yang SJ, Yokoyama A, Yokoyama T et al : Relationship between genetic polymorphisms of ALDH2 and ADH1B and esophageal cancer risk : a meta-analysis. World J Gastroenterol 16 : 4210-4220, 2010.
 
8) Yokoyama T, Yokoyama A, Kumagai Y et al : Health Risk Appraisal Models for Mass Screening of Esophageal Cancer in Japanese Men. Cancer Epidemiol Biomarkers Prev 17 : 2846-2854, 2008.
PubMed
9) Yokoyama A, Kumagai Y, Yokoyama T et al : Health risk appraisal models for mass screening for esophageal and pharyngeal cancer : an endoscopic follow-up study of cancer-free Japanese men. Cancer Epidemiol Biomarkers Prev 18 : 651-655, 2009.
PubMed
10) Yokoyama A, Oda J, Iriguchi Y et al : A healthrisk appraisal model and endoscopic mass screening for esophageal cancer in Japanese men. Dis Esophagus 26 : 148-153, 2013.
PubMed
11) Yokoyama A, Tsutsumi E, Imazeki H et al : Polymorphisms of alcohol dehydrogenase-1B and aldehyde dehydrogenase-2 and the blood and salivary ethanol and acetaldehyde concentrations of Japanese alcoholic men. Alcohol Clin Exp Res 34 : 1246-1256, 2010.
PubMed
12) Yokoyama A, Yokoyama T, Mizukami T et al : Blood ethanol levels of nonabstinent Japanese alcoholic men in the morning after drinking and their ADH1B and ALDH2 genotypes. Alcohol Alcohol 49 : 31-37, 2014.
PubMed
13) Yokoyama A, Kamada Y, Imazeki H et al : Effects of ADH1B and ALDH2 Genetic Polymorphisms on Alcohol Elimination Rates and Salivary Acetaldehyde Levels in Intoxicated Japanese Alcoholic Men. Alcohol Clin Exp Res 40 : 1241-1250, 2016.
PubMed
14) Yokoyama A, Yokoyama T, Matsui T et al : Trends in gastrectomy and ADH1B and ALDH2 genotypes in Japanese alcoholic men and their gene-gastrectomy, gene-gene and gene-age interactions for risk of alcoholism. Alcohol Alcohol 48 : 146-152, 2013.
 
15) Tanaka F, Yamamoto K, Suzuki S et al : Strong interaction between the effects of alcohol consumption and smoking on oesophageal squamous cell carcinoma among individuals with ADH1B and/or ALDH2 risk alleles. Gut 59 : 1457-1464, 2010.
PubMed
16) Yokoyama A, Mizukami T, Omori T et al : Melanosis and squamous cell neoplasms of the upper aerodigestive tract in Japanese alcoholic men. Cancer Sci 97 : 905-911, 2006.
PubMed
17) Yokoyama A, Yokoyama T, Muramatsu T et al : Macrocytosis, a new predictor for esophageal squamous cell carcinoma in Japanese alcoholic men. Carcinogenesis 24 : 1773-1778, 2003.
PubMed
18) Yokoyama A, Yokoyama T, Brooks PJ et al : Macrocytosis, macrocytic anemia, and genetic polymorphisms of alcohol dehydrogenase-1B and aldehyde dehydrogenase-2 in Japanese alcoholic men. Alcohol Clin Exp Res 38 : 1237-1246, 2014.
PubMed
19) Yokoyama A, Mizukami T, Yokoyama T : Genetic polymorphisms of alcohol dehydrogense-1B and aldehyde dehydrogenase-2, alcohol flushing, mean corpuscular volume, and aerodigestive tract neoplasia in Japanese drinkers. Adv Exp Med Biol 815 : 265-279, 2015.
PubMed
20) Akiyama T, Inamori M, Iida H et al : Alcohol consumption is associated with an increased risk of erosive esophagitis and Barrett's epithelium in Japanese men. BMC Gastroenterol 8 : 58, 2008.
 
21) Lee HS, Jeon SW : Barrett esophagus in Asia : same disease with different pattern. Clin Endosc 47 : 15-22, 2014.
PubMed
22) Matsuzaki J, Suzuki H, Kobayakawa M et al : Association of Visceral Fat Area, Smoking, and Alcohol Consumption with Reflux Esophagitis and Barrett's Esophagus in Japan. PLoS One 10 : e0133865, 2015.
PubMed
23) Liu SY, Han XC, Sun J et al : Alcohol intake and helicobacter pylori infection : A dose-response meta-analysis of observational studies. Infect Dis (Lond) : 1-7. [Epub ahead of print], 2015.
 
24) Yokoyama A, Omori T, Yokoyama T et al : Risk of metachronous squamous cell carcinoma in the upper aerodigestive tract of Japanese alcoholic men with esophageal squamous cell carcinoma : A long-term endoscopic follow-up study. Cancer Sci 99 : 1164-1171, 2008.
PubMed
25) Islami F, Sheikhattari P, Ren JS et al : Gastric atrophy and risk of oesophageal cancer and gastric cardia adenocarcinoma-a systematic review and meta-analysis. Ann Oncol 22 : 754-760, 2011.
PubMed
26) Yokoyama A, Yokoyama T, Omori T et al : Helicobacter pylori, chronic atrophic gastritis, inactive aldehyde dehydrogenase-2, macrocytosis and multiple upper aerodigestive tract cancers and the risk for gastric cancer in alcoholic Japanese men. J Gastroenterol Hepatol 22 : 210-217, 2007.
 
27) Matsuo K, Oze I, Hosono S et al : The aldehyde dehydrogenase 2 (ALDH2) Glu504Lys polymorphism interacts with alcohol drinking in the risk of stomach cancer. Carcinogenesis 34 : 1510-1515, 2013.
PubMed
28) Hidaka A, Sasazuki S, Matsuo K et al : Genetic polymorphisms of ADH1B, ADH1C and ALDH2, alcohol consumption, and the risk of gastric cancer : the Japan Public Health Center-based prospective study. Carcinogenesis 36 : 223-231, 2015.
PubMed
29) Yuzuriha T, Okudaira M, Tominaga I et al : Alcohol-related sudden death with hepatic fatty metamorphosis : a comprehensive clinicopathological inquiry into its pathogenesis. Alcohol Alcohol 32 : 745-752, 1997.
PubMed
30) Yokoyama A, Yokoyama T, Mizukami T et al : Alcoholic Ketosis : Prevalence, Determinants, and Ketohepatitis in Japanese Alcoholic Men. Alcohol Alcohol 49 : 618-625, 2014.
PubMed
31) Mizoue T, Tanaka K, Tsuji I et al : Alcohol drinking and colorectal cancer risk : an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 36 : 582-597, 2006.
PubMed
P.975 掲載の参考文献
1) 堀江義則 : 第1章 アルコール性肝障害の概論・疫学, 疫学動向. 高後裕編, 新しい診断と治療のABC, アルコール性肝障害, pp. 16-24, 最新医学社, 大阪, 2009.
 
2) 厚生労働省e-ヘルスネット : http://www.e-healthnet.mhlw.go.jp/information/alcohol/
 
3) 樋口進 : 成人の飲酒と生活習慣に関する実態調査研究. 平成20年度厚生労働科学研究補助金研究課報告書 : わが国における飲酒の実態ならびに飲酒に関連する生活習慣病. 公衆衛生上の諸問題とその対策に関する総合的研究, pp. 12-50, 2010.
 
4) 堀江義則, 海老沼浩利, 菊池真大他 : 本邦におけるアルコール性肝硬変の実態. 肝臓 56 : 366-368, 2015.
 
5) 鈴木康秋, 大竹孝明, 青柳豊他 : 我が国における非B非C肝硬変の実態. 高後裕編, 我が国における非B非C肝硬変の実態調査2011, pp. 6-16 響文社, 札幌, 2012.
 
6) 真栄里仁, 松下幸生 : 女性・高齢者の飲酒. Progress in Medicine 33 : 899-903, 2013.
Medical*Online
7) Higuchi S, Matsushita S, Muramatsu T et al : Alcohol and aldehyde dehydrogenase genotypes and drinking behavior in Japanease. Alcohol Clin Exp Res 20 : 493-497, 1996.
 
8) Duddempudi AT : Immunology in alcoholic liver disease. Clin Liver Dis 16 : 687-698, 2012.
PubMed
9) 藤田尚巳, 竹井謙之 : アルコール性肝障害. 臨床と研究 90 (2) : 176-182, 2013.
 
10) Tsutsumi M, Lasker JM, Shimizu M et al : The intralobular distribution of ethanol-inducible P4502E1 in rat and human liver. Hepatology 10 : 437-446, 1989.
 
11) Dugum M, McCullough A : Diagnosis and management of alcoholic liver disease. J Clin Transl Hepatol 3 (2) : 109-116, 2015.
PubMed
12) Rotily M, Durbec JP, Sarles H et al : Diet and alcohol in liver cirrhosis : a case-control study. Eur J Clin Nutr 44 : 595, 1990.
 
13) Naveau S, Giraud V, Borotto E et al : Excess weight risk factor for alcoholic liver disease. Hepatology 25 : 108, 1997.
PubMed
14) アルコール医学生物学研究会編 : アルコール性肝障害診断基準2011年版, 響文社, 札幌, 2012.
 
15) O'Shea RS, Dasarathy S, McCullough AJ : Alcoholic liver disease. Am J Gastroenterol 105 (1) : 14-32, 2010.
PubMed
16) European Association for the Study of Liver : EASL clinical practical guidelines : management of alcoholic liver disease. J Hepatol 57 (2) : 399-420, 2012.
 
17) Mason BJ : Treatment of alcohol-dependent outpatients with acamprosate : a clinical review. J Clin Psychiatry 62 : 42-48, 2001.
PubMed
18) 堀江義則, 山岸由幸, 海老沼浩利他 : 本邦におけるアルコール性肝炎の重症度判定のための新しいスコア. 肝臓 53 : 429-431, 2012.
 
19) Tokushige K, Hashimoto E, Horie Y et al : Hepatosellular carcinoma in Japanese patients with nonalcoholic fatty liver disease, alcoholic liver disease and chronic liver disease of unknown etiology : Report of the Nationwide Survey. J Gas troenterol 46 : 1230-1237, 2011.
 
20) 黒松亮子, 佐田通夫 : アルコール性肝障害に合併した肝細胞癌の特徴. アルコールと医生物 30 : 46-50, 2011.
 
P.981 掲載の参考文献
1) Friedrich N : Diseases of the Pancreas. Cyclopoedia of the Practice of Medicine (ed. by Ziemssen H), pp. 549-630, William Wood, New York, 1878.
 
2) Weiner HA, Tennant R : A statistical study of acute hemorrhagic pancreatitis (hemorrhagic necrosis of pancreas). Am J Med Sci 196 : 167-176, 1938.
 
3) Comfort MW, Gambill EE, Baggenstoss AH : Chronic relapsing pancreatitis ; a study of twenty-nine cases without associated disease of the biliary or gastro-intestinal tract. Gastroenterology 6 : 239-285, 1946.
PubMed
4) 日本膵臓学会膵癌診療ガイドライン改訂委員会 : 科学的根拠に基づく膵癌診療ガイドライン2013年版. 金原出版, 東京, 2013.
 
5) 正宗淳, 下瀬川徹 : アルコールと膵炎-酒を飲みすぎると膵炎になるか? 医学のあゆみ 222 : 661-666, 2007.
Medical*Online
6) 正宗淳, 下瀬川徹 : アルコールと膵炎. 日本消化器病学会雑誌 109 : 1526-1534, 2012.
Medical*Online
7) Hamada S, Masamune A, Kikuta K et al : Nationwide epidemiological survey of acute pancreatitis in Japan. Pancreas 43 : 1244-1248, 2014.
PubMed
8) Jupp J, Fine D, Johnson CD : The epidemiology and socioeconomic impact of chronic pancreatitis. Best Pract Res Clin Gastroenterol 24 : 219-231, 2010.
PubMed
9) 玉腰暁子, 林櫻松, 小川道雄他 : 急性膵炎の発生要因に関する症例対照研究. 厚生労働省特定疾患対策研究事業難治性膵疾患に関する調査研究班平成13年度研究報告書, pp. 47-59, 2002.
 
10) Phillip V, Huber W, Hagemes F et al : Incidence of acute pancreatitis does not increase during Oktoberfest, but is higher than previously described in Germany. Clin Gastroenterol Hepatol 9 : 995-1000, 2011.
 
11) Hirota M, Shimosegawa T, Masamune A et al : The seventh nationwide epidemiological survey for chronic pancreatitis in Japan : clinical significance of smoking habit in Japanese patients. Pancreatology 14 : 490-496, 2014.
PubMed
12) Garg PK, Tandon RK : Survey on chronic pancreatitis in the Asia-Pacific region. J Gastroenterol Hepatol 19 : 998-1004, 2004.
 
13) Kume K, Masamune A, Ariga H et al : Alcohol consumption and the risk for developing pancreatitis : a case-control study in Japan. Pancreas 44 : 53-58, 2015.
PubMed
14) Yadav D, Whitcomb DC : The role of alcohol and smoking in pancreatitis. Nat Rev Gastroenterol Hepatol 7 : 131-145, 2010.
PubMed
15) Laposata EA, Lange LG : Presence of nonoxidative ethanol metabolism in human organs commonly damaged by ethanol abuse. Science 231 : 497-499, 1986.
PubMed
16) Werner J, Laposata M, Fernandez-del Castillo C et al : Pancreatic injury in rats induced by fatty acid ethyl ester, a nonoxidative metabolite of alcohol. Gastroenterology 113 : 286-294, 1997.
 
17) Pandol SJ, Lugea A, Mareninova OA et al : Investigating the pathobiology of alcoholic pancreatitis. Alcohol Clin Exp Res 35 : 830-837, 2011.
PubMed
18) Apte MV, Pirola RC, Wilson JS : Mechanisms of alcoholic pancreatitis. J Gastroenterol Hepatol 25 : 1816-1826, 2010.
PubMed
19) Clemens DL, Schneider KJ, Arkfeld CK et al : Alcoholic pancreatitis : new insights into the pathogenesis and treatment. World J Gastrointest Pathophysiol 7 : 48-58, 2016.
PubMed
20) Gukovsky I, Gukovskaya AS : Impaired autophagy triggers chronic pancreatitis : lessons from pancreas-specific atg5 knockout mice. Gastroenterology 148 : 501-505, 2015.
PubMed
21) Fortunato F, Burgers H, Bergmann F et al : Impaired autolysosome formation correlates with Lamp-2 depletion : role of apoptosis, autophagy, and necrosis in pancreatitis. Gastroenterology 137 : 350-360, 2009.
PubMed
22) Apte MV, Phillips PA, Fahmy RG et al : Does alcohol directly stimulate pancreatic fibrogenesis? Studies with rat pancreatic stellate cells. Gastroenterology 118 : 780-794, 2000.
PubMed
23) Masamune A, Satoh A, Watanabe T et al : Effects of ethanol and its metabolites on human pancreatic stellate cells. Dig Dis Sci 55 : 204-211, 2010.
PubMed
24) Whitcomb DC : Gene-environment factors that contribute to alcoholic pancreatitis in humans. J Gastroenterol Hepatol 21 : S52-S55, 2006.
PubMed
25) Schneider A, Whitcomb DC, Singer MV : Animal models in alcoholic pancreatitis?what can we learn? Pancreatology 2 : 189-203, 2002.
PubMed
26) Pandol SJ, Periskic S, Gukovsky I et al : Ethanol diet increases the sensitivity of rats to pancreatitis induced by cholecystokinin octapeptide. Gastroenterology 117 : 706-716, 1999.
PubMed
27) Lugea A, Gong J, Nguyen J et al : Cholinergic mediation of alcohol-induced experimental pancreatitis. Alcohol Clin Exp Res 34 : 1768-1781, 2010.
PubMed
28) Haber P, Wilson J, Apte M et al : Individual susceptibility to alcoholic pancreatitis : still an enigma. J Lab Clin Med 125 : 205-312, 1995.
 
29) Lankisch PG, Lowenfels AB, Maisonneuve P : What is the risk of alcoholic pancreatitis in heavy drinkers? Pancreas 25 : 411-412, 2002.
PubMed
30) Andriulli A, Botteri E, Almasio PL et al : Smoking as a cofactor for causation of chronic pancreatitis : a meta-analysis. Pancreas 39 : 1205-1210, 2010.
PubMed
31) Maisonneuve P, Lowenfels AB, Mullhaupt B et al : Cigarette smoking accelerates progression of alcoholic chronic pancreatitis. Gut 54 : 510-514, 2005.
PubMed
32) Otsuki M, Tashiro M : Chronic pancreatitis and pancreatic cancer, lifestyle-related diseases. Intern Med 46 : 109-113, 2007.
PubMed
33) Whitcomb DC, LaRusch J, Krasinskas AM et al : Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis. Nat Genet 44 : 1349-1354, 2012.
PubMed
34) Masamune A, Nakano E, Hamada S et al : Common variants at PRSS1-PRSS2 and CLDN2-MORC4 loci associate with chronic pancreatitis in Japan. Gut 64 : 1345-1346, 2015.
PubMed
P.991 掲載の参考文献
1) Sico JJ, Amin H, Sorokin A et al : Neurologic disorders related to alcohol and other drug use. The ASAM principles of Addiction Medicine 5th. (ed. by Ries RK, Fiellin DA, Miller SC et al), pp. 1178-1194, Wolters Kluwer , Philadelphia, 2014.
 
2) Sechi GP, Serra A : Wernicke's encephalopathy : new clinical settings and recent advances in diagnosis and management. Lancet Neurol 6 : 442-455, 2007.
 
3) Ridley NJ, Draper B, Withall A : Alcoho-related dementia : an update of the evidence. Alzheimer's Research & Therapy 5 : 3, 2013.
 
4) Caine D, Haliday GM, Krill JJ et al : Operational criteria for the classification of chronic alcoholics : identification of Wernicke's encephalopathy. J Neurol Neurosurg Psychiatry 62 : 51-60, 1997.
 
5) Galvin R, Brathen G, Ivashynka A et al : EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy. Eur J Neurol 17 : 1408-1418, 2010.
PubMed
6) Zahr NM, Kaufman KL, Harper CG : Clinical and pathological features of alcohol-related brain damage. Nat Rev Neurol 7 : 284-294, 2011.
PubMed
7) Oslin D, Atkinson RM, Smith DM et al : Alcohol related dementia : proposed clinical criteria. Int J Geriatr Psychiatry 13 : 203-212, 1998.
PubMed
8) Blansjaar BA, Van Dijk JG : Korsakoff minus Wernicke syndrome. Alcohol Alcohol 27 : 435-437, 1992.
PubMed
9) 高橋三郎, 大野裕監訳 : DSM-5 精神疾患の診断・統計マニュアル, 医学書院, 東京, 2014.
 
10) Osaki Y, Kinjo A, Higuchi S et al : Prevalence and trends in alcohol dependence and alcohol use disorders in Japanese adults ; Results from periodical nationwide surveys. Alcohol Alcohol 51 : 465-473, 2016.
PubMed
11) Yokoyama A, Matsushita S, Ishii H et al : The impact of diabetes mellitus on the prognosis of alcoholics. Alcohol Alcohol 29 : 181-186, 1994.
PubMed
12) 松下幸生 : アルコール使用障害の診断・治療の進歩と今後の展望「薬物治療」. Progress in Medicine 33 : 87-91, 2013.
 
P.999 掲載の参考文献
1) 国税庁課税部酒税課 : 酒のしおり (平成27年3月), p. 28, 2015. https://www.nta.go.jp/shiraberu/senmonjoho/sake/shiori-gaikyo/shiori/2015/pdf/005.pdf#page=1
 
2) 堀江義則, 海老沼浩利, 金井隆典 : アルコール性肝障害を再考する, 本邦におけるアルコール性肝障害の実態. 日本消化器病学会雑誌 112 : 1630-1640, 2015.
 
3) Osaki Y, Kinjo A, Higuchi S et al : Prevalence and Trends in Alcohol Dependence and Alcohol Use Disorders in Japanese Adults ; Results from Periodical Nationwide Surveys. Alcohol and Alcoholism : 1-9, 2016.
PubMed
4) アルコール健康障害対策基本法 : http://www8.cao.go.jp/alcohol/pdf/kihonhou/hou.pdf
 
5) アルコール健康障害対策推進基本計画 : http://www8.cao.go.jp/alcohol/kihon_keikaku/pdf/kihon_keikaku.pdf
 
6) Anderson P, Gual A, Colom J : 2005 Alcohol and Primary Health Care : Clinical Guidelines on identification and Brief interventions, p. 6, Department of Health of the Government of Catalonia, Barcelona, 2005.
 

【研究】

P.1008 掲載の参考文献
1) Clinical and Laboratory Standards Institute : Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically ; Approved standard-tenth edition. M07-A10. Wayne, PA. 2015.
 
2) Clinical and Laboratory Standards Institute : Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria ; Approved guideline-second edition. M45-A2. Wayne, PA. 2010.
 
3) Clinical and Laboratory Standards Institute : Methods for antimicrobial susceptibility testing of anaerobic bacteria ; Approved standard-eighth edition. M11-A8. Wayne, PA. 2012.
 
4) Clinical and Laboratory Standards Institute : Performance standards for antimicrobial susceptibility testing ; twenty-fifth informational supplement. M100-S25. Wayne, PA. 2015.
 
5) Yanagihara K, Kadota J, Aoki N et al : Nationwide surveillance of bacterial respiratory pathogens conducted by the Surveillance Committee of the Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2010 : General view of the pathogens' antibacterial susceptibility. J Infect Chemother 21 : 410-420, 2015.
PubMed
6) Ishikawa K, Hamasuna R, Uehara S, et al : Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases. J Infect Chemother 21 : 623-633, 2015.
 
7) 厚生労働省院内感染対策サーベイランス事業. 2014年年報. http://www.nih-janis.jp/report/open_report/2014/3/1/ken_Open_Report_201400(clsi2012).pdf
 

【前臨床試験】

P.1016 掲載の参考文献
1) "Annual Report on the Aging Society : 2014 (Summary) -Cabinet Office Home Page". http://www8.cao.go.jp/kourei/english/annualreport/2015/2015pdf_e.html
 
2) Raz N, Gunning FM, Head D et al : Selective aging of the human cerebral cortex observed in vivo : differential vulnerability of the prefrontal gray matter. Cereb Cortex 7 (3) : 268-282, 1997.
PubMed
3) Baltes PB, Lindenberger U : Emergence of a powerful connection between sensory and cognitive functions across the adult life span : a new window to the study of cognitive aging? Psychol Aging 12 (1) : 12-21, 1997.
 
4) Geula C, Mesulam MM : Systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer's disease Cereb. Cortex 6 (2) : 165-177, 1996.
PubMed
5) Whitehouse PJ, Price DL, Clark AW et al : Alzheimer disease : evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 10 (2) : 122-126, 1981.
PubMed
6) Cohen EL, Wurtman RJ : Brain acetylcholine : control by dietary choline. Science 191 (4227) : 561-562, 1976.
PubMed
7) Signoret JL, Whiteley A, Lhermitte F : Influence of choline on amnesia in early Alzheimer's disease. Lancet (London, England) 2 (8094) : 837, 1978.
 
8) Thal LJ, Rosen W, Sharpless NS et al : Choline chloride fails to improve cognition of Alzheimer's disease. Neurobiol Aging 2 (3) : 205-208, 1981.
PubMed
9) Blake MG, Boccia MM, Krawczyk MC et al : Choline reverses scopolamine-induced memory impairment by improving memory reconsolidation. Neurobiol Learn Mem 98 (2) : 112-121, 2012.
PubMed
10) Bartus RT, Dean RL, Goas JA et al : Age-related changes in passive avoidance retention : modulation with dietary choline. Science 209 (4453) : 301-303, 1980.
PubMed
11) Mizumori SJ, Patterson TA, Sternberg H et al : Effects of dietary choline on memory and brain chemistry in aged mice. Neurobiol Aging 6 (1) : 51-56, 1985.
PubMed
12) Farlow MR, Cummings JL : Effective pharmacologic management of Alzheimer's disease. Am J Med 120 (5) : 388-397, 2007.
PubMed
13) Wiltgen BJ, Brown RAM, Talton LE et al : New circuits for old memories : the role of the neocortex in consolidation. Neuron 44 (1) : 101-108, 2004.
PubMed
14) Frankland PW, Bontempi B : The organization of recent and remote memories. Nat Rev Neurosci 6 (2) : 119-130, 2005.
PubMed
15) Nader K, Schafe GE LDJ : Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval. Nature 17 (6797) : 722-726, 2000.
 
16) Albuquerque EX, Pereira EFR, Alkondon M et al : Mammalian nicotinic acetylcholine receptors : from structure to function. Physiol Rev 89 (1) : 73-120, 2009.
PubMed
17) Boccia MM, Acosta GB, Blake MG et al : Memory consolidation and reconsolidation of an inhibitory avoidance response in mice : effects of i. c. v. injections of hemicholinium-3. Neuroscience 124 (4) : 735-741, 2004.
 
18) Kurisaki A, Inoue I, Kurisaki K et al : Activin induces long-lasting N-methyl-D-aspartate receptor activation via scaffolding PDZ protein activin receptor interacting protein 1. Neuroscience 151 (4) : 1225-1235, 2008.
PubMed
19) Kato A, Ozawa F, Saitoh Y et al : Novel members of the Vesl/Homer family of PDZ proteins that bind metabotropic glutamate receptors. J Biol Chem 273 (37) : 23969-23975, 1998.
PubMed
20) Johansson J, Formaggio E, Fumagalli G et al : Choline up-regulates BDNF and down-regulates TrkB neurotrophin receptor in rat cortical cell culture. Neuroreport 20 (9) : 828-832, 2009.
PubMed
21) Suzuki A, Fukushima H, Mukawa T et al : Upregulation of CREB-mediated transcription enhances both short- and long-term memory. J Neurosci 31 (24) : 8786-8802, 2011.
 
22) Taubenfeld SM, Milekic MH, Monti B et al : The consolidation of new but not reactivated memory requires hippocampal C/EBPbeta. Nat Neurosci 4 (8) : 813-818, 2001.
 
23) Lee JLC, Everitt BJ, Thomas KL : Independent cellular processes for hippocampal memory consolidation and reconsolidation. Science 304 (5672) : 839-843, 2004.
PubMed
P.1023 掲載の参考文献
1) Draelos ZD, Carter E, Maloney JM et al : Two randomized studies demonstrate the efficacy and safety of dapsone gel, 5% for the treatment of acne vulgaris. J Am Acad Dermatol 56 (3) : 439. e1-10, 2007.
 
2) 林伸和, 赤松浩彦, 岩月啓氏 他 : 尋常性ざ瘡治療ガイドライン2016. 日皮会誌126 (6) : 1045-1086, 2016.
 
3) Bernerd F, Ortonne JP, Bouclier M et al : The rhino mouse model : the effects of topically applied all-trans retinoic acid and CD271 on the fine structure of the epidermis and utricle wall of pseudocomedones. Arch Dermatol Res 283 (2) : 100-107, 1991.
PubMed
4) 宮井恵里子, 杉野公基 : 新規外用尋常性ざ瘡治療薬 アダパレンゲル (ディフェリンゲル0.1%) の薬理学的特性と臨床使用成績. 日本薬理学雑誌 134 (1) : 37-45, 2009.
 
5) Weiss JS, Thiboutot DM, Hwa J et al : Long-term safety and efficacy study of adapalene 0.3% gel. J Drugs Dermatol 7 (6) : s24-28, 2008.
 
6) 宮地良樹 : 本邦ざ瘡患者のアドヒアランス. 臨床皮膚科 67 (5) : 152-154.
 
7) Yamada M, Iihara H, Fujii H et al : Prophylactic Effect of Oral Minocycline in Combination with Topical Steroid and Skin Care Against Panitumumabinduced Acneiform Rash in Metastatic Colorectal Cancer Patients. Anticancer Res 35 (11) : 6175-6181, 2015.
PubMed
8) 竹村司, 遠野弘美, 与茂田敏他 : 尋常性ざ瘡患者に対する十味敗毒湯 (桜皮配合) の臨床効果と作用機序. 西日本皮膚科 76 (2) : 140-146, 2014.
 
9) 桜井みち代, 石川由香子, 大塚吉則他 : 漢方薬が奏効した脂漏性皮膚炎の5症例. 60 (2) : 155-159, 2009.
 
10) 羽白誠, 松本千穂, 滝尻珍重他 : アトピー性皮膚炎患者の皮膚症状に対する十味敗毒湯の効果-皮疹要素別の検討-. 皮膚の科学 10 (1) : 34-40, 2011.
 
11) 乃木田俊辰 : 炎症性皮疹を伴う尋常性ざ瘡に対する十味敗毒湯 内服とアダパレンゲル0.1%外用の併用療法の検討. 医学と薬学 67 (2) : 251-256, 2012.
 
12) 瀬川郁雄 : 十味敗毒湯によるざ瘡治療のアドヒアランス向上の試み. Phil 漢方 57 : 26-28, 2015.
 
13) Maurice E, Richerd D : アダパレンゲルの製造方法. 日本国特許公開広報2011-504912 (2011. 02. 17).
 
14) Bernard FX, Pedretti N, Rosdy M et al : Comparison of gene expression profiles in human keratinocyte mono-layer cultures, reconstituted epidermis and normal human skin ; transcriptional effects of retinoid treatments in reconstituted human epidermis. Exp Dermatol 11 (1) : 59-74, 2002.
PubMed
15) Babina M, Guhl S, Motakis E et al : The rhino mouse model : the effects of topically applied all-trans retinoic acid and CD271 on the fine structure of the epidermis and utricle wall of pseudocomedones. Mol Cell Endocrinol 406 (5) : 49-59, 2015.
 
16) Kurashima Y, Amiya T, Fujisawa K et al : The enzyme Cyp26b1 mediates inhibition of mast cell activation by fibroblasts to maintain skin-barrier homeostasis. Immunity 40 (4) : 530-541, 2014.
PubMed
17) Watanabe K, Karuppagounder V, Arumugam S et al : Pruni cortex ameliorates skin inflammation possibly through HMGB1-NFκB pathway in house dust mite induced atopic dermatitis NC/Nga transgenic mice. J Clin Biochem Nutr 56 (3) : 186-194, 2015.
 
18) Bodet C, La VD, Gafner S et al : A licorice extract reduces lipopolysaccharide-induced proinflammatory cytokine secretion by macrophages and whole blood. J Periodontol 79 (9) : 1752-1761, 2008.
 
19) Hwang YP, Kim HG, Choi JH et al : Saponins from the roots of Platycodon grandiflorum suppress ultraviolet A-induced matrix metalloproteinase-1 expression via MAPKs and NF-κB/AP-1-dependent signaling in HaCaT cells. Food Chem Toxicol 49 (12) : 3374-3382, 2011.
 
20) 有地滋 : 柴胡およびサイコサポニンの研究 : (2) サイコサポニンの抗炎症作用の機序について. 近畿大学医学雑誌 4 (1) : 73-78, 1979.
 
21) Yu JY, Ha JY, Kim KM et al : Anti-Inflammatory activities of licorice extract and its active compounds, glycyrrhizic acid, liquiritin and liquiritigenin, in BV2 cells and mice liver. Molecules 20 (7) : 13041-13054, 2015.
PubMed

【症例報告】

P.1030 掲載の参考文献
1) Shirouzu Y, Ohya Y, Suda H et al : Massive ascites after living donor liver transplantation with a right lobe graft larger than 0.8% of the recipients body weight. Clin Transplant 24 (4) : 520-527, 2010.
 
2) Cirera I, Navasa M, Rimola A et al : Ascites after liver transplantation. Liver Transpl 6 (2) : 157-162, 2000.
PubMed
3) Bruminhent J, Razonable RR : Management of cytomegalovirus infection and disease in liver transplant recipients. World J Hepatol 6 (6) : 370-383, 2014.
PubMed
4) Marcelin JR, Beam E, Razonable RR : Cytomegalovirus infection in liver transplant recipients : updates on clinical management. World J Gastroenterol 20 (31) : 10658-10667, 2014.
 
5) Stockmann C, Roberts JK, Knackstedt ED et al : Clinical pharmacokinetics and pharmacodynamics of ganciclovir and valganciclovir in children with cytomegalovirus infection. Expert Opin Drug Metab Toxicol 11 (2) : 205-219, 2015.
PubMed
6) Czock D, Scholle C, Rasche FM et al : Pharmacokinetics of valganciclovir and ganciclovir in renal impairment. Clin. Pharmacol Ther 72 (2) : 142-150, 2002.
PubMed
7) Mori T, Mori S, Kanda Y et al : Clinical significance of cytomegalovirus (CMV) antigenemia in the prediction and diagnosis of CMV gastrointestinal disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 33 (4) : 431-434, 2004.
PubMed
8) Matsumoto K, Shigemi A, Ikawa K et al : Risk factors for ganciclovir-induced thrombocytopenia and leukopenia. Biol Pharm Bull 38 (2) : 235-238, 2015.
PubMed
9) Venton G, Crocchiolo R, Furst S et al : Risk factors of Ganciclovir-related neutropenia after allogeneic stem cell transplantation : a retrospective monocentre study on 547 patients. Clin Microbiol Infect 20 (2) : 160-166, 2014.
 

【Diagnosis】

P.1035 掲載の参考文献
1) Takatsuki K : Discovery of adult T-cell leukemia. Retrovirology 2 : 16, 2005.
PubMed
2) VS Kalyanaraman, MG Sarngadharan, M Robert-Guroff et al : A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 218 (5) : 571-573, 1982.
 
3) 厚生労働科学研究班「本邦におけるHTLV-1感染及び関連疾患の実態調査と総合対策」平成22年度総括研究報告書 (研究代表者 : 山口一成) 平成23年3月
 
4) HTLV-1母子感染予防対策保健指導マニュアル (改訂版)
 
5) Lee H, Swanson P, Rosenblatt JD et al : Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors. Lancet 337 : 1435-1439, 1991.
PubMed
6) Feuer G, Green PL : Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2. Oncogene 24 : 5996-6004, 2005.
PubMed
P.1045 掲載の参考文献
1) 門脇孝, 永井良三他 : 肝・胆・膵疾疾患, 内科学, pp. 917-927, 西村書店, 東京, 2012.
 
2) Recommendations of the Immunization Practices Advisory Committee Update on Hepatitis B Prevention. CDC MMWR 36 (23) : 353-366, 1987.
 
3) HISCL HBsAb 試薬 添付文書 2014年2月改訂 (第9版).
 
4) 上杉里枝, 河口勝憲, 小野公美他 : 化学発光酵素免疫測定法 (CLEIA) を用いた改良試薬「ルミパルスプレストHBsAb-N」の試薬性能評価. 医学と薬学 68 (1) : 169-176, 2012.
Medical*Online
5) 藤原拓樹 : 全自動化学発光免疫測定装置ARCHITECTによるHBs 抗体測定の基礎的検討. 医学と薬学 42 (2) : 623-627, 1999.
 
6) AD Jack, AJ Hall, N Maine et al : What level of Hepatitis B Antibody is protective? JID 179 : 489-492, 1999.
 
7) Weekly epidemiological record 84 : 40 (405-420), 2009, issued by WHO.
 
8) 大根久美子他 : HBs 抗体価の測定方法間差 : HBワクチン接種者由来モノクローナルHBs抗体を用いた検証. 臨床病理 63 (8) : 907-912, 2015.
Medical*Online
9) 小方則夫 : 国際基準共有に向けたB型肝炎ウイルス感染防御HBs抗体評価標準化の必要性-本邦で汎用されるHBs抗体測定法の特性乖離-. 臨床病理 54 : 960-965, 2006.
 
10) 小方則夫, 船田久, 青柳豊 : B型肝炎ワクチン (HBワクチン) と抗HB人免疫グロブリン (HBIG) の適応と効果 : 我が国におけるB型肝炎ウイルス (HBV) 感染予防対策の現状と課題. 日本臨牀 69 (増刊号4) : 408-416, 2011.
 

【Health Care】

P.1054 掲載の参考文献
1) Anand P, Kunnumakkara AB, Newman RA et al : Bioavailability of curcumin : problems and promises. Mol Pharm 4 : 807-818, 2007.
PubMed
2) Morimoto T, Sunagawa Y, Kawamura T et al : The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. J Clin Invest 118 : 868-878, 2008.
PubMed
3) Sunagawa Y, Morimoto T, Wada H et al : A natural p300-specific histone acetyltransferase inhibitor, curcumin, in addition to angiotensin-converting enzyme inhibitor, exerts beneficial effects on left ventricular systolic function after myocardial infarction in rats. Circ J 75 : 2151-2159, 2011.
PubMed
4) Yamauchi Y, Izumi Y, Yamamoto J et al : Coadministration of erlotinib and curcumin augmentatively reduces cell viability in lung cancer cells. Phytother Res 28 : 728-735, 2014.
PubMed
5) Kanai M : Therapeutic applications of curcumin for patients with pancreatic cancer. World J Gastroenterol 20 : 9384-9391, 2014.
PubMed
6) Lam P, Cheung F, Tan H Y et al : Hepatoprotective Effects of Chinese Medicinal Herbs : A Focus on Anti-Inflammatory and Anti-Oxidative Activities. Int J Mol Sci 17 (4), 2016.
PubMed
7) Wang L, Lv Y, Yao H et al : Curcumin prevents the non-alcoholic fatty hepatitis via mitochondria protection and apoptosis reduction. Int J Clin Exp Pathol 8 (9) : 11503-11509, 2015.
PubMed
8) Varatharajalu R, Garige M, Leckey L C et al : Protective Role of Dietary Curcumin in the Prevention of the Oxidative Stress Induced by Chronic Alcohol with respect to Hepatic Injury and Antiatherogenic Markers. Biochem Mol Med, 2016.
 
9) Tonnesen HH : Solubility, chemical and photochemical stability of curcumin in surfactant solutions. Studies of curcumin and curcuminoids, XXVIII. Pharmazie 57 : 820-824, 2002.
PubMed
10) Lao CD, Ruffin MT, Normolle D et al : Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 6 : 10, 2006.
PubMed
11) Sasaki H, Sunagawa Y, Takahashi K et al : Innovative Preparation of Curcumin for Improved Oral Bioavailability : Biol Pharm Bull 34 (5) : 660-665, 2011.
PubMed
12) Yang KY, Lin LC, Tseng TY et al : Oral bioavailability of curcumin in rat and the herbal analysis from Curcuma longa by LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 853 : 183-189, 2007.
 
13) Sugawara J, Akazawa N, Miyaki A et al : Effect of endurance exercise training and curcumin intake on central arterial hemodynamics in postmenopausal women : pilot study. Am J Hypertens 25 : 651-656, 2012.
PubMed
14) Akazawa N, Choi Y, Miyaki A et al : Effects of curcumin intake and aerobic exercise training on arterial compliance in postmenopausal women. Artery Res 7 : 67-72, 2013.
 
15) Nakagawa Y, Mukai S, Yamada S et al : Shortterm effects of highly-bioavailable curcumin for treating knee osteoarthritis : a randomized, double-blind, placebo-controlled prospective study. J Orthop Sci 19 : 933-939, 2014.
 
P.1065 掲載の参考文献
1) Department of Psychiatry, University of Tsukuba Dementia prevalence in the urban area and correspondence to life functional disorder of dementia. Available from : http://www.Tsukuba-psychiatry.com.2014
 
2) Tanigawa D, Misu S, Sawa R : Cross-sectional relationships between depression and psychological elements of pain for elderly people requiring long-term care. Psychogeriatrics 2 : 177-184, 2014.
 
3) Kiyohara Y : Advances in aging and health research. Japan Foundation for Aging and Health 1 : 25-34, 2013.
 
4) Snowdon DA : Nun Study. Healthy aging and dementia : findings from Nun Study. Ann Intern Med 139 : 450-454, 2003.
PubMed
5) Francis PT, Palmer AM, Snape M et al : The cholinergic hypothesis of Alzheimer's disease : a review of progress. J Neurol Neurosurg Psychiatry 66 : 137-147, 1999.
PubMed
6) Kawas CH : Clinical practice. Early Alzheimer's disease. N Engl J Med 349 : 1056-1063. 2003.
PubMed
7) Yaguchi T, Nagata T, Nishizaki T : 1-Palmitoyl-2-oleoyl-sn-glycero- 3-phosphocholine improves cognitive decline by enhancing long-term depression. Behav Brain Res 204 : 129-132, 2009.
PubMed
8) Nishizuka Y : Protein kinase C and lipid signaling for the expression. FASEB J 9 : 484-496, 1995.
 
9) Ikeuchi Y, Nishizaki T, Matsuoka T et al : Long-lasting enhancement of ACh receptor currents by lysophospholipids. Mol Brain Res 45 : 317-320, 1997.
PubMed
10) Cohen EL, Wurtman RJ : Brain acetylcholine : control by dietary choline. Science 191 : 561-562, 1976.
PubMed
11) Johansson J, Formaggio E, Fumagalli G et al : Choline up-regulates BDNF and down-regulates TrkB neurotrophin receptor in rat cortical cell culture. Neuroreport 20 : 828-832, 2009.
PubMed
12) Tayebati SK, Marucci G, Santinelli C et al : Choline-Containing Phospholipids : Structure-Activity Relationships Versus Therapeutic Applications. Curr Med Chem 22 (38) : 4328-4340. 2015.
PubMed
13) Matsuyama S, Matsumoto A, Enomoto T et al : Activation of nicotinic acetylcholine receptors induces long-term potentiation in vivo in the intact mouse dentate gyrus. Eur J Neurosci 12 : 3741-3747, 2000.
PubMed
14) Miyamoto H, Yaguchi T, Ohta K et al : 2-pyrrolidinone induces a long-lasting facilitation of hippocampal synaptic transmission by enhancing α7ACh receptor responses via a PKC pathway. Mol Brain Res 117 : 91-96, 2003.
 
15) Nishizaki T, Nomura T, Matuoka T et al : The anti-dementia drug nefiracetam facilitates hippocampal synaptic transmission by functionally targeting presynaptic nicotinic ACh receptors. Mol Brain Res 80 : 53-62, 2000.
PubMed
16) Nishizaki T, Nomura T, Matsuyama S et al : Critical role of presynaptic nicotinic ACh receptor in the formation of long-term potentiation : implication of development of anti-dementia drug. Psychogeriatrics 1 : 209-217, 2001.
 
17) Nishizaki T, Nomura T, Matsuoka T et al : Arachidonic acid as a messenger for the expression of long-term potentiation. Biochem Biophys Res Commun 254 : 446-449, 1999.
PubMed
18) Ikeuchi Y, Nishizaki T, Matsuoka T et al : Arachidonic acid potentiates ACh receptor currents by protein kinase C activation but not by receptor phosphorylation. Biochem Biophys Res Commun 221 : 716-721, 1996.
 
19) Nishizaki T, Ikeuchi Y, Matsuoka T et al : Shortterm depression and long-term enhancement of ACh-gated channel currents induced by linoleic and linolenic acid. Brain Res 751 : 253-258, 1997.
PubMed
20) Nishizaki T, Matsuoka T, Nomura T et al : Modulation of ACh receptor currents by arachidonic acid. Mol Brain Res 57 : 173-179, 1998.
PubMed
21) Nishizaki T, Nomura T, Matsuoka T et al : Arachidonic acid induces a long-lasting facilitation of hippocampal synaptic transmission by modulating PKC activity and nicotinic ACh receptors. Mol Brain Res 69 : 263-272, 1999.
PubMed
22) Nomura T, Nishizaki T, Enomoto T et al : A long-lasting facilitation of hippocampal neurotransmission via a phospholipase A2 signaling pathway. Life Sci 68 : 2885-2891, 2001.
 
23) Yaguchi T, Yamamoto S, Nagata T et al : Effects of cis-unsaturated free fatty acids on PKC-ε activation and nicotinic ACh receptor responses. Mol. Brain Res 133 : 320-324, 2005.
 
24) Nishizaki T, Sumikawa K : Lysophosphatidic acid potentiates ACh receptor currents by G-protein-mediated activation of protein kinase C. Mol Brain Res 50 : 121-126, 1997.
PubMed
25) Ross RG, Hunter SK, McCarthy L et al : Perinatal choline effects on neonatal pathophysiology related to later schizophrenia risk. Am J Psychiatry 170 (3) : 290-298, 2013.
PubMed
26) Tsukahara T, Haniu H, Matsuda Y et al : Shortterm treatment with a 2-carba analog of cyclic phosphatidic acid induces lowering of plasma cholesterol levels in ApoE-deficient mice. Biochem Biophys Res Commun 473 (1) : 107-113, 2016.
PubMed
27) Tsukahara T, Tsukahara R, Haniu H et al : Cyclic phosphatidic acid inhibits the secretion of vascular endothelial growth factor from diabetic human coronary artery endothelial cells through peroxisome proliferator-activated receptor gamma. Mol Cell Endocrinol 412 : 320-329. 2015.
PubMed
28) Wang Y, Cella M, Mallinson K et al : TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model. Cell 160 (6) : 1061-1071. 2015.
 
29) Jay TR, Miller CM, Cheng PJ et al : TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer's disease mouse models. J Exp Med 212 (3) : 287-295. 2015
PubMed
30) 認知機能の維持または改善剤. 特願2015-239120
 

【Cosmetic】

P.1078 掲載の参考文献
1) 化粧品機能評価法検討委員会 : <化粧品機能評価法ガイドライン> 新規効能取得のための抗シワ製品評価ガイドライン. 日本香粧品学会誌 30 (4) : 316-332, 2006.
 
2) 内村洋一郎 : しわ発生のメカニズム. 有限会社ブッカーズ編, アンチ･エイジングシリーズ No. 2 皮膚の抗老化最前線, 株式会社エヌ･ティー･エス, 東京, pp. 52-61, 2006.
 
3) 田上八朗 : 皮膚のバリア, 保湿メカニズム研究の進歩. フレグランスジャーナル36 (5) : 15-21, 2008.
 
4) 川崎由明, 坂本一民, Maibach HI : In vitro によるアミノ酸のヒト皮膚での経皮吸収挙動の解析. 日本化粧品技術者会誌 30 (1) : 55-61, 1996.
 
5) 小山純一, 森川良広, 松本勲 : ヒト角層中の遊離アミノ酸の挙動. 日本化粧品技術者会誌 15 (1) : 45-53, 1981.
 
6) 野口千笑, 山村達郎, 山本泰之 : 脂質二分子膜の水分保持作用に対するアミノ酸の影響. 日本化粧品技術者会誌 29 (1) : 49-54, 1995.
 
7) Hashizume E, Nakano T, Kamimura A et al : Topical effect of N-acetyl-L-hydroxyproline on ceramide synthesis and alleviation of pruritus. Clin Cosmet Investig Dermatol 6 : 43-49, 2013.
 
8) Cohen IK, Diegelmann RF : Effect of N-acetylcis-4-hydroxyproline on collagen synthesis. Exp Mol Pathol 28 (1) : 58-64, 1978.
 

書評

最近チェックした商品履歴

Loading...